leisure time -WSS

leisure time

author：hotspot 2025-10-01 20:06:34 - browse：836

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medicare Advantage overpayments discussion gets experts fired up

hotspot

WSS

Medicare drug price negotiation legal challenge met with skepticism

Merck, Johnson & Johnson CEOs will testify on high drug prices

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

American taxpayers paid $1.8 trillion in health care costs in 2022

Venture capital firm's plans to take over Akron hospital face hurdles

FDA early review: GLP

hotspot

leisure time

focus

The cancer drug shortage isn’t new — and neither are the solutions

Does Paxlovid work in people vaccinated against Covid

The high cost of giving birth even with insurance

Stories you might have missed in 2023: health, science, medicine

State Dept. review finds Biden bears some blame for Afghanistan failures

Profiling embryos to choose those with higher IQs is almost a reality

Drug repurposing or repositioning? The language matters

Pancreatic cancer early detection could be helped by AI

United colonoscopy coverage change 'may cost lives,' doctors say

Wegovy leads to weight loss. Can it treat depression, too?

hotspot

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

A preacher's new calling: Diversifying neuroscience research

Philips to halt sales of sleep apnea machines in U.S.

Ascension's ugly legal battle over care for poor patients in Texas

In shift, Texas to cover initial consult for Afghan baby's gene therapy

hotspot

Wikipedia

explore

explore